Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders

Antipsychotic for dementia-related agitation, contaminated water at Camp Lejeune associated with elevated risk for Parkinson's, gene variant confers resilience against autosomal dominant Alzheimer's.

Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology

50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia

Novel PET radiotracer, GLP-1s and dementia risk, green space benefits

Pegivirus' role in Parkinson's disease, GLP-1s and idiopathic intracranial hypertension, geographic spread of epilepsy specialists

Food deserts and stroke risk, physical activity in Parkinson's disease, rimegepant for migraine

Parkinson's and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG

Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists

Divisive treatment for cluster headache, head positioning before thrombectomy, new series, "Neurology in America"

New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine

Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia

Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.

Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.

Advances in cell therapies for Parkinson's, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs

Microplastics in brain, salary gap in neurology, the neurology of space

Impact of high-dose Vitamin D on MS relapse, the role of AI in neurology education, and a 4D animal model that shows precursors of MS lesions before they appear.

New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants

Impact of NIH cuts on neurology research, response to ACP's guideline on migraine, an updated position on seizures, driver licensure, and medical reporting

Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists